Chapter 16

This is a listing of all citations in this chapter.

61

Thomas L. “Buzz” Rempfer, Unyielding: Marathons against Experimental Vaccines, 226, to be published fall of 2023 by Tactical 16.

62

Ibid., 263.

63

Francis A. Boyle, Biowarfare and Terrorism (Atlanta: Clarity Press, 2005), 13.

64

US Congress, House, Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001, Public Law 107-56, 115 Stat. 272 (2001).

65

Office of Inspector General, “DHS Needs a Unified Strategy to Counter Disinformation Campaigns,” US Department of Homeland Security, Aug. 10, 2022.

66

US Department of Homeland Security, “Summary of Terrorism Threat to the US Homeland,” National Terrorism Advisory System Bulletin, Feb. 7, 2022.

67

US Congress, House, Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001, Public Law 107-56, 115 Stat. 272 (2001).

68

Ibid.

69

Barbara Hatch Rosenberg, “Allergic Reaction: Washington’s Response to the BWC Protocol,” Arms Control Association, Jul. 2001.

70

Susan Wright, “Bioweapons: US Vetoes Verification,” Bulletin of the Atomic Scientists 58, no. 2, (2002).

71

Dr. Francis Boyle, email message to Robert F. Kennedy Jr., Dec. 20, 2022.

72

Federal Bureau of Investigation, “Amerithrax or Anthrax Investigation,” FBI History.

73

Stephen Engelberg, “New Evidence Adds Doubt to FBI’s Case against Anthrax Suspect,” ProPublica, Oct. 10, 2011.

74

Brad Friedman, “‘Anthrax killer’ Remains a Mystery,” The Guardian, Aug. 11, 2008.

75

“Review of the Scientific Approaches Use During the FBI’s Investigation of the 2001 Bacillus Anthracis Mailing,” National Academies, 2011.

76

“Anthrax: Agency Approaches to Validation and Statistical Analyses Could Be Improved,” U.S. Government Accountability Office, Dec. 19, 2014.

77

Robert F. Kennedy Jr., Private Interview with Meryl Nass, MD.

78

Francis A. Boyle, Biowarfare and Terrorism (Atlanta: Clarity Press, 2005), 43.

79

Ibid., 44.

80

Judith Miller, “Next to Old Rec Hall, a ‘Germ-Making Plant’,” New York Times, Sep. 4, 2021.

81

Colonel Michael J. Ainscough, “Next Generation Bioweapons: The Technology of Genetic Engineering Applied to Biowarfare and Bioterrorism,” USAF Counterproliferation Center, April 2002.

82

Ibid.

83

Ibid.

84

Steven M. Block, “Living Nightmares: Biological Threats Enabled by Molecular Biology,” in The New Terror: Facing The Threat of Biological and Chemical Weapons (Stanford: Hoover Institution Press, 1999), 44.

85

Susan Wright, “Terrorists and Biological Weapons,” Politics and the Life Sciences 25, no. 1 (2006): 57-115, doi: 10.2990/1471-5457(2006)25[57:TABW]2.0.CO;2.

86

Colonel Michael J. Ainscough, “Next Generation Bioweapons: The Technology of Genetic Engineering Applied to Biowarfare and Bioterrorism,” USAF Counterproliferation Center, April 2002.

87

Ibid.

88

Lili Kuo et al., “Retargeting of Coronavirus by Substitution of the Spike Glycoprotein Ectodomain: Crossing the Host Cell Species Barrier,” Journal of Virology 74, no. 3 (2000): 1393-1406, doi: 10.1128/jvi.74.3.1393-1406.2000.